Protect Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '18 Jun 30, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Net Income	-0.02	-0.12	-0.04	-0.64	0.46	-0.02
Stock-Based Compensation	-	-	0	0.01	0.01	0.01
Other Operating Activities	0	0.1	0.01	0.61	-0.46	0.02
Change in Accounts Payable	0	0.02	0.01	0.01	-0.01	-0
Change in Other Net Operating Assets	0.01	0.01	-	-	-	-
Operating Cash Flow	0	-	-0.01	-0.02	-0	-0
Short-Term Debt Issued	-	-	0.01	0.02	-	-
Total Debt Issued	0.02	-	0.01	0.02	-	-
Net Debt Issued (Repaid)	0.02	-	0.01	0.02	-	-
Financing Cash Flow	0.02	-	0.01	0.02	-	-
Net Cash Flow	0.02	-	-0	-0	-0	-0
Levered Free Cash Flow	-	-	-	-0.03	-0.49	0.01
Unlevered Free Cash Flow	-	-	-	-0.03	-0.49	0.01
Change in Working Capital	0.01	0.02	0.01	0.01	-0.01	-0

Updated Mar 6, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.